| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/09/2003 | CA2239498C Bioartificial devices and cellular matrices therefor |
| 09/04/2003 | WO2003073238A2 Computational method for designing enzymes for incorporation of amino acid analogs into proteins |
| 09/04/2003 | WO2003073067A2 Rna detection enzymes |
| 09/04/2003 | WO2003073062A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 09/04/2003 | WO2003072811A2 The use of ribozymes in the detection of adventitious agents |
| 09/04/2003 | WO2003072801A2 Compositions and method for regulation of calcium-dependent signalling in brain |
| 09/04/2003 | WO2003072787A2 Method for detection of leptin receptor ligands |
| 09/04/2003 | WO2003072784A1 Delta 6-desaturases from primulaceae, expressing plants and pufa-containing oils |
| 09/04/2003 | WO2003072776A1 Gene encoding novel enzyme catalyzing glycosyl transfer reaction and process for producing the enzyme |
| 09/04/2003 | WO2003072765A1 Process for sorting motile particles from lesser-motile particles and apparatus suitable therefor |
| 09/04/2003 | WO2003072764A1 Hepatocyte bioreactor system for long term culture of functional hepatocyte spheroids |
| 09/04/2003 | WO2003072751A2 Expression system for human brain-specific voltage-gated sodium channel, type 1 |
| 09/04/2003 | WO2003072750A2 Expression of hiv-related proteins in plants |
| 09/04/2003 | WO2003072748A2 Bioengineered tissue substitutes |
| 09/04/2003 | WO2003072746A2 Subtilisin carlsberg proteins with reduced immunogenicity |
| 09/04/2003 | WO2003072740A2 Novel type-1 cytokine receptor glm-r |
| 09/04/2003 | WO2003072739A2 Trans-splicing mediated imaging of gene expression |
| 09/04/2003 | WO2003072732A2 Methods of making hypermutable cells using pmsr homologs |
| 09/04/2003 | WO2003072728A2 Cellular trans-differentiation |
| 09/04/2003 | WO2003072715A2 Gasp1: a follistatin domain containing protein |
| 09/04/2003 | WO2003072714A2 Follistatin domain containing proteins |
| 09/04/2003 | WO2003072707A2 Compositions comprising reproductive cell media and methods for using such compositions |
| 09/04/2003 | WO2003072700A2 Androgen receptor overexpressing skeletal myoblasts |
| 09/04/2003 | WO2003072699A2 Device and method for determining relative synthesis capacity of individual cells and/or position coordinates |
| 09/04/2003 | WO2003072698A2 Surface proteins of leptospira |
| 09/04/2003 | WO2003072697A2 Device and method for cultivating tissue cells |
| 09/04/2003 | WO2003072608A1 Anti-human tenascin monoclonal antibody |
| 09/04/2003 | WO2003072542A2 Interfacial biomaterials |
| 09/04/2003 | WO2003072037A2 High-level production of amyloid-beta peptides from imr-32 cells |
| 09/04/2003 | WO2003072035A2 Compositions and methods for the treatment of immune related diseases |
| 09/04/2003 | WO2003072014A2 Minicell compositions and methods |
| 09/04/2003 | WO2003071933A2 Novel compositions and methods for cancer |
| 09/04/2003 | WO2003071861A2 Vanillin biosynthetic pathway enzyme from vanilla planifolia |
| 09/04/2003 | WO2003071859A2 Methods for increasing the amount of protein in potato tubers |
| 09/04/2003 | WO2003053224A3 Novel compositions and methods for cancer |
| 09/04/2003 | WO2003036267A3 Filtration system and method for obtaining a cytology layer |
| 09/04/2003 | WO2003030922A3 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 09/04/2003 | WO2003029423A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/04/2003 | WO2003025151A3 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 09/04/2003 | WO2003025126A3 Compositions and methods for t cell priming and immunotherapy |
| 09/04/2003 | WO2003014366A3 Rna amplification system using plant components in animal cells |
| 09/04/2003 | WO2002103016A3 Human tachykinin-related splice variants and compositions thereof |
| 09/04/2003 | WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 09/04/2003 | WO2002101044A3 Brain expressed gene and protein associated with bipolar disorder |
| 09/04/2003 | WO2002097395A3 P-cadherin as a target for anti-cancer therapy |
| 09/04/2003 | WO2002096947A3 The lectin-like domain of thrombomodulin and its therapeutic use |
| 09/04/2003 | WO2002083858A8 Methods to inhibit viral replication |
| 09/04/2003 | WO2002081647A3 Bioluminescent plants and methods of making same |
| 09/04/2003 | WO2002079238A3 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 09/04/2003 | WO2002078600A3 γεRACK PEPTIDE COMPOSITION AND METHOD FOR PROTECTION AGAINST TISSUE DAMAGE DUE TO ISCHEMIA |
| 09/04/2003 | WO2002072127A3 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 09/04/2003 | WO2002070703A3 Cell visual characteristic-modifying sequences |
| 09/04/2003 | WO2002064792A3 Molecules for disease detection and treatment |
| 09/04/2003 | WO2002061041A3 Solubility reporter gene constructs |
| 09/04/2003 | WO2002060919A3 Molecules with extended half-lives, compositions and uses thereof |
| 09/04/2003 | WO2002055698A3 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 09/04/2003 | WO2002053775A3 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 09/04/2003 | WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 09/04/2003 | WO2002046237A3 Humanized antibodies that recognize beta amyloid peptide |
| 09/04/2003 | WO2002046220A3 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 09/04/2003 | WO2002040995A3 Method for estimating metabolic function of xenobiotic and induction thereof |
| 09/04/2003 | WO2002036807A3 Compositions and methods relating to breast specific genes and proteins |
| 09/04/2003 | WO2002036770A3 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 09/04/2003 | WO2002034923A9 Monocotyledon plant cells and plants which synthesise modified starch |
| 09/04/2003 | WO2002032943A9 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 09/04/2003 | WO2002013760A9 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 09/04/2003 | WO2002008456A3 Method for identifying metastatic tumor cells |
| 09/04/2003 | WO2001092299A3 Adenovirus particles with mutagenized fiber proteins |
| 09/04/2003 | WO2001085193A3 Method for promoting neovascularization using a tweak agonist and an angiogenic factor |
| 09/04/2003 | WO2001066595A9 Human fgf-23 gene and gene expression products |
| 09/04/2003 | WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 09/04/2003 | US20030167539 Genetically modified plants having modulated flower development |
| 09/04/2003 | US20030167538 Genetic engineered plants; corn, wheat, rice |
| 09/04/2003 | US20030167536 Plant adpglucose pyroghophatase, method for the production thereof, its use in the production of assay devices and for obtaining transgenic plants |
| 09/04/2003 | US20030167529 Plants synthesizing a modified starch, a process for the generation of the plants, their use, and the modified starch |
| 09/04/2003 | US20030167528 Lyases; replicating libraries; transgenic plants |
| 09/04/2003 | US20030167527 Transgenic plant; genetic engineering |
| 09/04/2003 | US20030167525 Desaturase genes and uses thereof |
| 09/04/2003 | US20030167522 Obtained from Bacillus thuringiensis (cry proteins); for activity against corn rootworm pests |
| 09/04/2003 | US20030167521 Genetic engineered insecticide |
| 09/04/2003 | US20030167517 Cry proteins for recombination within plant cells |
| 09/04/2003 | US20030167514 For screening/conferring tolerance in plants |
| 09/04/2003 | US20030167511 Production of p-hydroxybenzoic acid |
| 09/04/2003 | US20030167502 Human monoclonal antibodies to dendritic cells |
| 09/04/2003 | US20030167500 Methods and compositions for generating a genetically modified animal using lentiviral vectors |
| 09/04/2003 | US20030167496 Transgenic non-human mammals carrying human pituitary tumor transforming gene (PTTG) sequences |
| 09/04/2003 | US20030167495 Comprises spinocerebellar ataxias (SCAs) genes; neurodegenerative disorders; homologous recombination; genes |
| 09/04/2003 | US20030167494 Stretch-activated sodium channel modulators |
| 09/04/2003 | US20030167491 Inositol 1,4,5-triphosphate receptors (IP3R); ankyrin-B; for treatment of cardiac hypertrophy, diabetes, pancreas, respiratory system disorders, blood disorders, vision disorders, endocrine inbalance, and/or pain/inflammation |
| 09/04/2003 | US20030167489 For transgenic mice that produce high levels of humanizing antibodies; immunoglobulins |
| 09/04/2003 | US20030167487 Homologous recombination; stem cells; drug screening; platelets |
| 09/04/2003 | US20030167486 Double transgenic mice overexpressing human beta secretase and human APP-London |
| 09/04/2003 | US20030166915 Retrovirus from the HIV group and its use |
| 09/04/2003 | US20030166911 Hybrid nucleic acids; genetic engineering |
| 09/04/2003 | US20030166910 Bone morphogenic protein |
| 09/04/2003 | US20030166908 Seafood protein; measuring water absorption of fish bladder |
| 09/04/2003 | US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents |
| 09/04/2003 | US20030166897 Diagnosis, therapy cancer; transgenic animal |
| 09/04/2003 | US20030166895 Gene expression; genetic engineering; central nervous system disorders; cardiovascular disorders; glandular disorders; psychological disorders |
| 09/04/2003 | US20030166891 Novel Bt toxin receptors from lepidopteran insects and methods of use |